Outcome for Patients With War-Associated Extremity Wound Infection
NCT ID: NCT03463720
Last Updated: 2018-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
843 participants
OBSERVATIONAL
2010-09-27
2012-05-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimal Antibiotics for Operated Diabetic Foot Infections
NCT04081792
Randomised Control Study to Asses the Role of Negative Pressure Wound Therapy (NPWT) in the Management of Wound in Surgical Patient
NCT02331485
The Effect of Negative Pressure Wound Therapy on Wound Healing in Major Amputations of the Lower Limb
NCT04618406
Tracking Wound Infection With Smartphone Technology
NCT02704897
Trial of Negative-pressure Wound Therapy Use in Conflict-related Extremity Wounds
NCT02444598
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
War-associated injuries are generally treated according to the ICRC war surgical protocol. Research on the epidemiology of and risk factors for wound infection in patients with war-associated injuries is limited and primarily include military combatants, leading to a selection of young males. Due to the use of body armor and forward surgical teams this data may not be applicable to a civilian setting. It is unknown to what extent wound infection itself is a factor contributing to serious complications such as amputation and death. Knowledge is needed to gear resources towards those most in need. This research makes use of a unique database that contains both civilians and combatants of both sexes and all ages. The investigators aim to assess whether the infection itself affects patient outcome (i.e. amputation, death) when comparing patients with and patients without infection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Extremity wound
Patients with extremity wounds. Infected and not infected patients will be compared.
Infected
Extremity wound, infected
Not infected
Extremity wounds, non-infected
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Infected
Extremity wound, infected
Not infected
Extremity wounds, non-infected
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients that present at the hospital within 72 hours of injury
* Patients with valid data on baseline wound status.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The International Federation of Red Cross and Red Crescent Societies
OTHER
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonas Malmstedt
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonas Malmstedt, PhD
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
International Committee of the Red Cross hospital
Peshawar, Khyber Pakhtunkhwa, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KISOS003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.